顺式-4-羟基-D-脯氨酸盐酸盐 | 77449-94-6

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - 脯氨酸类衍生物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 顺式-4-羟基-D-脯氨酸盐酸盐
• 中文别名: 顺式-(D)-4-羟基脯氨酸盐酸盐；顺式-D-羟脯氨酸盐酸盐；(2R,4R)-4-羟基吡咯烷-2-羧酸盐酸盐；顺-4-羟基-D-脯氨酸(盐酸盐形式的)；顺式-4-羟基-脯氨酸盐酸盐
• 英文名称: (2R,4R)-4-hydroxypyrrolidine-2-carboxylic acid hydrochloride
• 英文别名: (2R,4R)-4-hydroxyproline hydrochloride；Allo-4-hydroxy-D-proline Hydrochloride；cis-4-Hydroxy-D-proline hydrochloride；cis-4-hydroxy-L-proline hydrochloride；cis-4-hydroxy-R-proline hydrochloride；cis-4-hydroxy-D-proline；(2R,4R)-4-hydroxypyrrolidine-2-carboxylic acid;hydrochloride
• CAS: 77449-94-6
• 化学式: C₅H₉NO₃*ClH
• mdl: MFCD08693622
• 分子量: 167.592
• InChiKey: YEJFFQAGTXBSTI-VKKIDBQXSA-N

物化性质

• 熔点：
  114-116 °C

计算性质

• 辛醇/水分配系数(LogP)：
  -3.72
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  69.6
• 氢给体数：
  4
• 氢受体数：
  4

安全信息

• 海关编码：
  2933990090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  2~8℃

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Cis-4-Hydroxy-D-proline, HCl
Synonyms: (2R,4R)-4-Hydroxypyrrolidine-2-carboxylic acid hydrochloride

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Cis-4-Hydroxy-D-proline, HCl
CAS number: 77449-94-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C5H9NO3.ClH
Molecular weight: 167.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

生物化学

反应信息

• 作为反应物：
  描述：

  顺式-4-羟基-D-脯氨酸盐酸盐 在 锂硼氢 、 氯化亚砜 、 sodium hydride 、 三乙胺 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 29.17h， 生成 tert-butyl (2R,4R)-4-((tert-butyldimethylsilyl)oxy)-2-(methoxymethyl)pyrrolidine-1-carboxylate
  参考文献：
  名称：

  TW2017/8221

  摘要：

  公开号：
• 作为产物：
  描述：

  L-羟基脯氨酸 在 乙酸酐 、 溶剂黄146 、 盐酸 作用下， 以 水 为溶剂， 反应 8.5h， 以75%的产率得到顺式-4-羟基-D-脯氨酸盐酸盐
  参考文献：
  名称：

  骨架中具有环状结构的四种肽核酸单体的设计和立体选择性合成

  摘要：

  肽核酸（PNA）单体的四个异构体衍生自（2 S，4 R）-4-羟基脯氨酸; 它们在吡咯烷环的C 2和C 4位置具有不同的立体化学。通过组合在吡咯烷环中C 2和C 4位置上的转化，实现了与四个不同立体化学相对应的这些不同的主链构象。将获得的主链骨架与N-苯甲酰基胸腺嘧啶反应，得到相应的PNA单体。所得单体的光谱比较证实了其​​立体化学。J.杂环化​​学。（2011）。

  DOI：

  10.1002/jhet.627

文献信息

• Synthesis of (1<i>R</i>,4<i>R</i>)- and (1<i>S</i>,4<i>S</i>)-2,5-Diazabicyclo[2.2.1]heptanes and Their<i>N</i>-Substituted Derivatives
  作者：Ulrich Jordis、Fritz Sauter、Suhaib M. Siddiqi、Bernhard Küenburg、Kaberi Bhattacharya

  DOI：10.1055/s-1990-27056

  日期：——

  Derivatives of the (1R,4R)- and (1S,4S)-2,5-diazabicyclo- [2.2.1]heptane ring system are prepared in enantiomerically pure form from trans-4-hydroxy-L-proline (2). The target compounds are precursors of antibacterial quinolone carboxyclic acids.

  (1R,4R)-和(1S,4S)-2,5-二氮杂双环[2.2.1]庚烷环系的衍生物以对映体纯形式从反式-4-羟基-L-脯氨酸（2）中制备而成。目标化合物是抗菌喹啉羧酸的前体。
• Amino acids bearing nucleobases for the synthesis of novel peptide nucleic acids
  作者：Gordon Lowe、Tirayut Vilaivan

  DOI：10.1039/a603696a

  日期：——

  All of the four nucleobases found in DNA have been incorporated in their protected form into the 4-position of N-tert-butoxycarbonyl-L-proline methyl ester with cis-stereochemistry. An efficient route for the synthesis of N-tert-butoxycarbonyl-trans-4-hydroxy-D -proline methyl ester has been developed from which the enantiomers may be synthesized. In addition an efficient synthesis of N-tert-butoxycarbonyl-N-(2-hydroxyethyl)glyc ine methyl ester has been achieved and its hydroxy group replaced with protected nucleobases using the Mitsunobu reaction

  DNA中的所有四种核苷酸碱基均已以其保护形式整合到了N-叔丁氧羰基-L-脯氨酸甲酯的4-位，并保持顺式立体化学结构。从N-叔丁氧羰基-反式-4-羟基-D-脯氨酸甲酯的高效合成路线中，可以制备其对映体。此外，还实现了N-叔丁氧羰基-N-(2-羟乙基)甘氨酸甲酯的高效合成，并通过 Mitsunobu 反应将其羟基替换为保护的核苷酸碱基。
• MINERALOCORTICOID RECEPTOR ANTAGONISTS AND METHODS OF USE
  申请人：GAVARDINAS Konstantinos

  公开号：US20090163472A1

  公开（公告）日：2009-06-25

  The present invention provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart failure, hypertension, diabetic nephropathy, or chronic kidney disease, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof.

  本发明提供了一种式(I)化合物： 或其药学上可接受的盐；包含式(I)化合物与适宜载体、稀释剂或赋形剂的药物组合物；以及治疗生理障碍，特别是充血性心力衰竭、高血压、糖尿病肾病或慢性肾病的方法，包括给予式(I)化合物或其药学上可接受的盐。
• [EN] SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS<br/>[FR] COMPOSÉS DE SULFONAMIDE HÉTÉROCYCLIQUES SUBSTITUÉS UTILES COMME MODULATEURS DE TRPA1
  申请人：HOFFMANN LA ROCHE

  公开号：WO2015052264A1

  公开（公告）日：2015-04-16

  The invention is concerned with the compounds of formula I or II: and salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I or II as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.

  本发明涉及式I或II的化合物及其盐。此外，本发明还涉及制备这些化合物的方法以及使用这些化合物的方法，以及含有这些化合物的药物组合物。这些化合物可能对治疗由TRPA1介导的疾病和状况，如疼痛，具有用途。
• [EN] PYRROLIDINE GPR40 MODULATORS<br/>[FR] MODULATEURS PYRROLIDINES DE GPR40
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2014078609A1

  公开（公告）日：2014-05-22

  The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.

  本发明提供了式(I)的化合物：或其立体异构体，或其药物可接受的盐，其中所有变量均如本文所述定义。这些化合物是GPR40 G蛋白偶联受体的调节剂，可用作药物。